bluebird bio, Inc. (BLUE) has signed first Medicaid outcomes-based agreement for LYFGENIA with the state of Michigan. LYFGENIA is a one-time gene therapy approved for the treatment of patients 12 years of age and older with sickle cell disease and a history of vaso-occlusive events.
No party has gained majority in the Portuguese parliamentary election, making chances of forming a majority government grim. Winning 79 seats, the centre-right Democratic Alliance claimed narrow victory over the ruling Socialists (SP), which won 77 seats.
Stock of Eli Lilly and Company (LLY) is moving down over 4 percent on Monday, despite no corporate-specific news to influence the stock movement. Currently, Eli Lilly's shares are sliding 4.
Stock of Eli Lilly and Company (LLY) is moving down over 4 percent on Monday, despite no corporate-specific news to influence the stock movement. Currently, Eli Lilly's shares are sliding 4.
Robotics company, B.O.S. Better Online Solutions Ltd. (BOSC), Monday announced that it received an offer worth 615,000 euros from an Israeli defense-industry customer.